Clik here to view.
ERYTECH获得EuropaBio颁发的2014年度欧洲生物技术SME最具创新性奖
法国里昂 (美国商业资讯) — ERYTECH (Paris:ERYP)(Euronext Paris: FR0011471135 – ERYP)是一家法国生物制药公司，开发用于急性白血病和医治需求未获满足的其他肿瘤适应证的创新性“肿瘤饥饿法”治疗，该公司获得EuropaBio颁发的2014年度欧洲生物技术SME最具创新性奖。...
View ArticleClik here to view.
Clik here to view.
Covidien促进全球提高对血栓风险的知晓度
爱尔兰都柏林 (美国商业资讯)– Covidien plc今天宣布，该公司将作为全球伙伴，支持世界血栓日的启动活动，这是全球应对静脉血栓栓塞(VTE)威胁的努力的一部分。国际血栓和瘀血学会(ISTH)将于2014年10月13日展开该活动，藉此契机凸显VTE的负担和病损及死亡风险1。 ISTH主席、UNC Health Care和UNC医学院血液科医生Nigel...
View ArticleClik here to view.
米国ボストン・ストラテジクス社：制がん剤臨床試験で採取された患者さんの腫瘍組織を駆使したトランスレーショナル研究に関して米国モレキュラー・レスポンス社との...
ボストン （ビジネスワイヤ） — 米国マサチューセッツ州ボストンに本社を置く臨床ステージの総合医薬品研究開発会社...
View ArticleClik here to view.
BioNet Provides Update on Recombinant Acellular Pertussis Vaccine at BioJapan...
YOKOHAMA, Japan BioNet-Asia’s CEO, Dr Pham Hong Thai provided today an update on the company lead vaccine program in his presentation at BioJapan 2014. Dr Pham said that the current Phase I/II trial...
View ArticleClik here to view.
Focus on Excellence in Endoscopy: PENTAX Medical at UEGW 2014
HAMBURG, Germany PENTAX Medical will be presenting the latest technologies and programmes designed to ensure excellence in endoscopy on Stand 9, Hall Y at UEGW 2014, Vienna, 18th-22nd October....
View ArticleClik here to view.
Clik here to view.
Dr. Reddy’s to Release Q2 FY15 Results on October 29, 2014
HYDERABAD, India Dr. Reddy’s Laboratories (NYSE: RDY) will announce results for the Second Quarter ended September 30, 2014 on Wednesday, October 29, 2014 after the Board Meeting. The results will...
View ArticleClik here to view.
Macrogen Introduces Latest Service Portfolio and Presents Research Outcome at...
SAN DIEGO, Calif. & SEOUL, South Korea The integrated genomic service provider, Macrogen (www.macrogen.com) (KRX 038290) has announced its plans to launch new service portfolio and hold an...
View ArticleClik here to view.
R-Tech Ueno: Announcement of Initiation of the Phase I Clinical Trial for the...
TOKYO R-Tech Ueno (JASDAQ: 4573): We are pleased to announce that as of today, the company has started the phase one clinical trial for the new molecular entity RTU-1096, which is a vascular...
View ArticleClik here to view.
Personalis and the Garvan Institute Announce Commercial Partnership for Whole...
MENLO PARK, Calif. & SYDNEY Personalis, Inc., a leading genomics-based clinical research and diagnostics global service provider based in the USA, and the Garvan Institute of Medical Research in...
View ArticleClik here to view.
昆泰荣获临床研究中心协会颁发的2014年鹰奖
北卡罗来纳州三角研究园 (美国商业资讯)–昆泰(Quintiles)今天宣布该公司荣获临床研究中心协会(Clinical Research Sites, SCRS)颁发的2014年临床研究机构(CRO)鹰奖(Eagle Award)。该奖项在年度SCRS研究中心解决方案峰会(Site Solutions Summit)上颁发，旨在表彰卓越的领导力、专业性、诚信、热情和奉献精神。...
View ArticleClik here to view.
Humacyte Selected to Join U.S. Secretary of Commerce On Trade Mission to Asia
RESEARCH TRIANGLE PARK, N.C. Humacyte, a pioneer in regenerative medicine, today announced it will join U.S. Secretary of Commerce Penny Pritzker on a Development Mission to Japan and South Korea...
View ArticleClik here to view.
Hatchtech Announces Successful Results from Phase 2 Ovicidal Study
MELBOURNE, Australia Specialty pharmaceutical company Hatchtech Pty Ltd today announced positive results from a Phase 2 clinical study evaluating the ovicidal efficacy (ability to kill lice eggs) of...
View ArticleClik here to view.
GVK BIO宣布成功完成药物创新应用，以确定新的适应证
印度海德拉巴德 (美国商业资讯)–亚洲领先的整合式发现研发组织GVK Biosciences (GVK BIO)今天宣布，采用GVK BIO拥有专利的药物创新应用(Drug Repurposing)平台，为武田制药株式会社(Takeda Pharmaceutical Company...
View ArticleClik here to view.
GVK BIOが新しい適応症発見のための医薬品再開発事業を成功裏に完了と発表
印ハイデラバード （ビジネスワイヤ） — アジア一流の総合創薬・研究開発組織であるGVKバイオサイエンシズ（GVK BIO）は本日、武田薬品工業株式会社向けに、GVK BIO専有の医薬品再開発プラットフォームを活用して、棚上げされた化合物の代替適応症をコンピューター上で確認することに成功したと発表しました。GVK...
View ArticleClik here to view.
GVK BIO Announces Successful Completion of Drug Repurposing Efforts to...
HYDERABAD, India GVK Biosciences (GVK BIO), Asia’s leading integrated Discovery Research and Development organization, today announced the successful completion of in-silico based alternative...
View ArticleClik here to view.
Macrogen Selects GenoLogics’ Clarity LIMS to Strengthen X-Genome and Clinical...
SEOUL, South Korea & SAN FRANCISCO The personalized medicine biotechnology company Macrogen (www.macrogen.com) has announced it has licensed Clarity LIMS from GenoLogics Life Sciences Software...
View ArticleClik here to view.
マクロジェンがX-Genomeサービスおよび臨床シーケンシングサービスを強化するためジェノロジックスのClarity LIMSを選定
韓国ソウル & サンフランシスコ （ビジネスワイヤ） — 個別化治療薬バイオテクノロジー企業のマクロジェン（www.macrogen.com）は、オミックス・ラボ専用にデザインされたLIMSの大手プロバイダーであるジェノロジックス・ライフ・サイエンシズ・ソフトウエア（www.genologics.com）より、Clarity...
View ArticleClik here to view.
Macrogen选择GenoLogics的Clarity LIMS来加强X基因组和临床测序服务
韩国首尔和旧金山 (美国商业资讯)–个体化医学生物技术公司Macrogen (www.macrogen.com)宣布，已从GenoLogics Life Sciences Software (www.genologics.com)获得Clarity LIMS的授权，以支持其全基因组测序和临床测序服务，GenoLogics是专为基因组学实验室设计的LIMS的领先提供商。...
View Article